The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.

With more than 50 million redeemed miles under her belt, Becky Pokora is a rewards travel expert. She's been writing about credit cards and reward travel since 2011 with articles on Forbes Advisor ...

Platinum chemotherapy utilization declined by 15.1% at the height of the national shortage. The shortage did not translate to an increase in short-term mortality. The shortage of generic ...

Immunotherapy enhances your immune system’s ability to target cancer cells. Chemotherapy acts directly on cancer cells to keep them from replicating. Immunotherapy and chemotherapy are two ...

Also, adding authorized users does come at a price: You’ll pay $195 for each additional Platinum card. Earn 80,000 Membership Rewards® Points after you spend $8,000 on eligible purchases on ...

The protocol will enable new enrollment expressly focusing on patients with advanced, recurrent, platinum-resistant disease, a group that has shown durable clinical benefit from stenoparib in the ...

In this review, we provide an updated overview of the progress made in recent years concerning ICB therapy assisted by FUS-controlled small-molecule delivery systems ... applied thermally ablative FUS ...

Human immunoconjugate molecule (hI-con1 ... Our group has recently evaluated the activity of hI-con1 against primary chemotherapy-resistant USC. Immunohistochemical analysis demonstrated TF ...